Risk factors for discontinuation of s-1 adjuvant chemotherapy for gastric cancer.
Kawazoe H, Shimasaki M, Ueno M, Sumikawa S, Takatori S, Namba H, Yoshida M, Sato K, Kojima Y, Watanabe Y, Moriguchi T, Tanaka A, Araki H.
Kawazoe H, et al. Among authors: tanaka a.
J Cancer. 2015 Mar 18;6(5):464-9. doi: 10.7150/jca.11189. eCollection 2015.
J Cancer. 2015.
PMID: 25874010
Free PMC article.